课题基金 / 基金详情

Prevention of reperfusion liver injury by SOD-(DIVEMA) conjugate

Prevention of reperfusion liver injury by SOD-(DIVEMA) conjugate
SOD-(DIVEMA) 结合物预防再灌注肝损伤
批准号:
06455003
负责人:
TODOROKI Takeshi
金额:
$4.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

TODOROKI Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
通过二乙烯基醚与马来酸酐共聚物(DIVEMA)合成平均分子量为30000和5000,分子量分布较窄(Wm/Mn=1.4)的偶联物,建立了体外和体内延长超氧化物歧化酶(SOD)活性的方法。人血浆中SOD酶活性在139 min内下降50%,而SOD- divema在24 h内没有下降。注射到小鼠体内的SOD在6分钟内失去50%的活性,而结合物中SOD的半衰期为69分钟。偶联DIVEMA可显著降低SOD的抗原性,提高SOD的温度稳定性。同时,本课题新开发了一套活体荧光外显照明电视显微观察分析系统,以评估DIVEMA偶联对肝脏微循环再灌注损伤的预防效果。用荧光素钠和罗丹明6g染色血清和白细胞。在我们新开发的外延照像显微镜下记录门静脉脱栓后30min的肝脏微循环。门静脉痉挛持续30分钟,并在剥离前1分钟给予一种测试药物。灌注率(No。每针灌注正弦波数/正弦波总数)、小叶内黏附和滚动白细胞数、黏附和滚动白细胞率(No。黏附和滚动白细胞数/总数以肝窦后中央小静脉内通过的白细胞数量作为肝再灌注损伤的指标。与SOD相比,SOD- divema偶联物对再灌注损伤的预防作用显著(p<0.05)。另一方面,与未处理的对照相比,SOD在各施用指标上的微循环表现不显著。
英文摘要
Procedures for prolongation of superoxide dismutase (SOD) activity both in vitro and in vivo were established by synthesizing the conjugates with the copolymer of the divinyl ether and maleic anhydride (DIVEMA), which have average molecular weigh of 30,000 and 5,000 and narrow molecular weigh distribution (Wm/Mn=1.4). The enzymatic activity of SOD decreased to 50% within 139 min.in human plasma, on the contrary SOD-DIVEMA showed no decrease in 24 hr. SOD injected into mice lost 50% of its activity within 6 min., whereas a half life of SOD in conjugate was 69 min. The conjugating of DIVEMA markedly diminished antigenicity of SOD and increased the stability for temperature. While, an intravital fluorescence epi-illuminated television microscopic observation and analyzing system was newly developed by this Grant in order to estimate the efficacy of conjugating with DIVEMA on the prevention of reperfusion injury of the liver microcirculation. Sodium fluorescein and Rodamin-6G were used for staining serum and leukocyte. The liver microcirculation was recorded under our newly developed epi-illumination video microscope for 30min.after decramping the portal vein. Cramping of the portal vein was continued for 30 min.and a tested drug was administered one min.prior to decramping. The perfusion rate (No.of perfusing sinusoid per acine/Total number of sinusoid), the number of sticking and rolling leukocytes in the lobulus, and the rate of sticking and rolling leukocytes (No.of sticking and rolling leukocytes/total No.of passsing leukocyte) in the post sinusoidal central venule were used as indicators for the reperfusion injury of the liver. Administration of SOD-DIVEMA conjugate prevented reperfusion injury significantly (p<0.05) in compare to SOD administration. On the other hand SOD showed insignificantly better microcirculation estimated in every applied indicators than non treated control.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
加藤 修志: "ジビニルエーテル無水マレイン酸共重合体(DIVEMA)結合によるSOD酵素活性の延長" Drug Delivery System. 9(5). 325-330 (1994)
Shuji Kato:“通过二乙烯基醚马来酸酐共聚物 (DIVEMA) 结合延长 SOD 酶活性”药物输送系统 9(5)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
SHUJI KATO,TAKASHI HIRANO,TAKESHI TODOROKI,KATASHI FUKAO,SHINICHI OHASHI: "Prolonged enzymatic activity of SOD by conjugation of the enzyme with copolymer of divinyl ether and maleic anhydride (DIVEMA)" Drug Deivery System. 9(5). 325-330 (1994)
SHUJI KATO、TAKASHI HIRANO、TAKESHI TODOROKI、KATASHI FUKAO、SHINICHI OHASHI:“通过酶与二乙烯基醚和马来酸酐共聚物 (DIVEMA) 的结合来延长 SOD 的酶活性”药物输送系统。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takashi Hirano: "Synthesis of the Conjugate of superoxide dismutase with the copolymer of the divinyal ether and maleic anhydride retaining enzymatic activity" Journal of Controled Release. 28. 203-209 (1994)
Takashi Hirano:“超氧化物歧化酶与保留酶活性的二乙烯基醚和马来酸酐的共聚物的缀合物的合成”《控制释放杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
TAKASHI HIRANO,TAKESHI TODOROKI,et al: "Synthesis of the conjugate of superoxide dismutase with the copolymer of divinyl ether and maleic anhydride retaining enzymatic activity" Journal of Controlled Release. 28. 203-209 (1994)
TAKASHI HIRANO,TAKESHI TODOROKI,等人:“用二乙烯基醚和马来酸酐的共聚物合成超氧化物歧化酶缀合物,保留酶活性”《控释杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    Mucin glycoproteins in human gallbladder carcinoma and their biological effects on tumor invasion and metastasis capability.
    • 批准号:
      13671279
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2001
    • 负责人:
      TODOROKI Takeshi
    • 依托单位:
    Protection of hepatic microcirculatory disturbance due to the ischemia-reperfusion injury
    • 批准号:
      13671278
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      TODOROKI Takeshi
    • 依托单位:
    The effect of TAK-O44 combined with SOD-DIVEMA on ischemia reperfusion liver injury.
    • 批准号:
      11671208
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1999
    • 负责人:
      TODOROKI Takeshi
    • 依托单位:
    SDUDIES OF HIGH MOLECULAR SUBSTANCE- SOD CONJUGATE ON PREVENSION OF HEPATIC ISCHEMLA-REPERFUSION INJURY AND HEPATIC MICROCIRCULATION
    • 批准号:
      08671410
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.47万
    • 财政年份:
      1996
    • 负责人:
      TODOROKI Takeshi
    • 依托单位:
    国内基金
    海外基金
    锌通过调节 SoxR 中[2Fe-2S]簇稳态调控肠杆菌科 SoxS-SOD 轴参与氧化应激机制及抗菌应用研究
    • 批准号:
      ZCLZ26C0101
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谭国强
    • 依托单位:
    过表达GABPA靶向激活SOD3减轻氧化应激保护小鼠免受强直性脊柱炎导致的损伤
    • 批准号:
      2026JJ82278
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      吴文欣
    • 依托单位:
    柳穿鱼黄素通过PPARγ/SOD2轴抑制铁死亡减轻小鼠胆汁淤积性肝损伤的机制研究
    植物乳杆菌CCFM8661通过PGC-1α/SIRT3/SOD2通路在铅致肾损伤中的保护作用和机制研究
    • 批准号:
      2025JJ80782
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      詹丽超
    • 依托单位: